NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



Findings from M. Hanif and co-authors provide new insights into tuberculosis



February 17th, 2009

"State TB Demonstration Centre, Delhi, India. To obtain a baseline estimate of the prevalence of multidrug-resistant tuberculosis (MDR-TB) among previously treated tuberculosis (TB) cases at the State Tuberculosis Centre in 2006," researchers in New Delhi, India report.

"A retrospective study. Drug susceptibility data of 5252 previously treated patients tested at this centre were analysed. Of 2880 Mycobacterium tuberculosis isolates from previously treated cases, 1498 (52%) were resistant to one or more anti-tuberculosis drugs, of which 47.1% were MDR. Resistance to isoniazid was observed in all resistant isolates, followed by resistance to rifampicin in 1357 (47.1%),...


Source: TB & Outbreaks Week (2009-02-17)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login